Universe Pharmaceuticals annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Free Cash Flow (FCF) History (UPC)
Universe Pharmaceuticals reported −$5.32B in free cash flow for fiscal 2025, an increase of $4.40B from the previous fiscal year, with a free cash flow margin of −29.78%.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-09-30 | −$5.32B | $4.40B | — | −29.78% |
| 2024 | 2024-09-30 | −$9.72B | −$10.83B | — | −42.19% |
| 2023 | 2023-09-30 | $1.12B | $1.12B | — | +3456.44% |
| 2022 | 2022-09-30 | −$1.4M | $1.1M | — | −3.48% |
| 2021 | 2021-09-30 | −$2.5M | −$8.6M | — | −5.21% |
| 2020 | 2020-09-30 | $6.1M | −$7.1M | −53.78% | +19.75% |
| 2019 | 2019-09-30 | $13.1M | — | — | +39.48% |
Universe Pharmaceuticals quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Universe Pharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $6.1M to −$5.32B, a net decrease of $5.33B.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Universe Pharmaceuticals filings at SEC.gov ↗